| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Proteins | 19 | 2023 | 205 | 1.810 |
Why?
|
| Membrane Proteins | 18 | 2023 | 485 | 1.500 |
Why?
|
| Fatty Acids, Unsaturated | 13 | 2022 | 66 | 1.300 |
Why?
|
| Retina | 15 | 2024 | 433 | 1.180 |
Why?
|
| Retinal Degeneration | 14 | 2020 | 150 | 1.130 |
Why?
|
| Retinal Rod Photoreceptor Cells | 8 | 2024 | 90 | 0.990 |
Why?
|
| Macular Degeneration | 9 | 2023 | 84 | 0.950 |
Why?
|
| Docosahexaenoic Acids | 10 | 2024 | 91 | 0.890 |
Why?
|
| Retinal Cone Photoreceptor Cells | 6 | 2020 | 126 | 0.760 |
Why?
|
| Spinocerebellar Ataxias | 4 | 2023 | 28 | 0.750 |
Why?
|
| Fatty Acids | 11 | 2020 | 204 | 0.720 |
Why?
|
| Mutation | 10 | 2022 | 848 | 0.690 |
Why?
|
| Animals | 45 | 2025 | 10399 | 0.500 |
Why?
|
| Mice | 32 | 2025 | 4645 | 0.470 |
Why?
|
| Phospholipids | 5 | 2024 | 76 | 0.450 |
Why?
|
| Light | 6 | 2015 | 118 | 0.400 |
Why?
|
| Synaptic Membranes | 2 | 2023 | 3 | 0.340 |
Why?
|
| Cell Membrane | 7 | 2023 | 260 | 0.340 |
Why?
|
| Sucrose | 2 | 2023 | 28 | 0.340 |
Why?
|
| Sphingolipids | 1 | 2010 | 20 | 0.340 |
Why?
|
| Rod Cell Outer Segment | 6 | 2008 | 42 | 0.320 |
Why?
|
| Photoreceptor Cells, Vertebrate | 4 | 2020 | 67 | 0.310 |
Why?
|
| Rhodopsin | 4 | 2015 | 40 | 0.300 |
Why?
|
| Rats | 13 | 2021 | 1564 | 0.300 |
Why?
|
| Phosphatidylcholines | 4 | 2017 | 45 | 0.290 |
Why?
|
| Liver | 4 | 2025 | 434 | 0.290 |
Why?
|
| Electroretinography | 11 | 2020 | 178 | 0.270 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2014 | 35 | 0.260 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2025 | 43 | 0.230 |
Why?
|
| Mice, Knockout | 8 | 2025 | 845 | 0.230 |
Why?
|
| Coenzyme A Ligases | 1 | 2024 | 6 | 0.230 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2025 | 27 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 55 | 0.230 |
Why?
|
| Fatty Liver | 1 | 2025 | 57 | 0.220 |
Why?
|
| Disease Models, Animal | 10 | 2021 | 1461 | 0.220 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2025 | 67 | 0.220 |
Why?
|
| Neurons | 3 | 2017 | 282 | 0.210 |
Why?
|
| Peroxisomes | 1 | 2023 | 3 | 0.210 |
Why?
|
| Erythrokeratodermia Variabilis | 1 | 2022 | 3 | 0.200 |
Why?
|
| Semen | 2 | 2022 | 29 | 0.200 |
Why?
|
| Centrifugation, Density Gradient | 3 | 2023 | 26 | 0.200 |
Why?
|
| Mice, Transgenic | 10 | 2017 | 509 | 0.200 |
Why?
|
| Ceramides | 2 | 2013 | 24 | 0.200 |
Why?
|
| Seizures | 2 | 2023 | 48 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2023 | 133 | 0.190 |
Why?
|
| Phosphatidylethanolamines | 3 | 2017 | 26 | 0.180 |
Why?
|
| Cattle | 6 | 2016 | 389 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2021 | 22 | 0.180 |
Why?
|
| Male | 16 | 2025 | 13487 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 50 | 0.180 |
Why?
|
| Cell Fractionation | 2 | 2023 | 18 | 0.180 |
Why?
|
| Macula Lutea | 1 | 2020 | 5 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2018 | 633 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2025 | 1433 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2016 | 252 | 0.170 |
Why?
|
| Organ Specificity | 2 | 2010 | 82 | 0.170 |
Why?
|
| Hepatocytes | 2 | 2025 | 78 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2019 | 11 | 0.160 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2020 | 97 | 0.160 |
Why?
|
| Spermatozoa | 1 | 2019 | 33 | 0.150 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2014 | 19 | 0.150 |
Why?
|
| Blotting, Western | 7 | 2016 | 510 | 0.150 |
Why?
|
| Gene Deletion | 2 | 2016 | 118 | 0.150 |
Why?
|
| Brain | 2 | 2017 | 739 | 0.150 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 2 | 2008 | 3 | 0.150 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2018 | 8 | 0.150 |
Why?
|
| Chromatography, Gas | 5 | 2010 | 18 | 0.150 |
Why?
|
| Pyruvate Kinase | 1 | 2018 | 10 | 0.140 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 402 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 2018 | 66 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 6 | 2025 | 1570 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2014 | 29 | 0.140 |
Why?
|
| Rod Opsins | 3 | 2009 | 14 | 0.140 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 20 | 0.140 |
Why?
|
| Endoplasmic Reticulum | 2 | 2014 | 80 | 0.130 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2014 | 6 | 0.130 |
Why?
|
| Female | 15 | 2023 | 15156 | 0.130 |
Why?
|
| Hippocampus | 1 | 2017 | 189 | 0.130 |
Why?
|
| Transport Vesicles | 1 | 2016 | 8 | 0.130 |
Why?
|
| Cyclic N-Oxides | 1 | 2015 | 26 | 0.130 |
Why?
|
| Retinal Diseases | 1 | 2015 | 47 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 136 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2019 | 113 | 0.120 |
Why?
|
| Fertility | 2 | 2019 | 58 | 0.120 |
Why?
|
| Humans | 15 | 2025 | 28121 | 0.120 |
Why?
|
| Chromatography, Thin Layer | 3 | 2010 | 18 | 0.120 |
Why?
|
| Arthritis, Experimental | 1 | 2014 | 6 | 0.110 |
Why?
|
| Synaptosomes | 1 | 2014 | 9 | 0.110 |
Why?
|
| Osteoarthritis | 1 | 2014 | 36 | 0.110 |
Why?
|
| Lipids | 3 | 2023 | 208 | 0.110 |
Why?
|
| Apoptosis | 4 | 2018 | 771 | 0.110 |
Why?
|
| Propylene Glycols | 1 | 2013 | 3 | 0.100 |
Why?
|
| Testis | 2 | 2010 | 35 | 0.100 |
Why?
|
| Sphingosine | 1 | 2013 | 22 | 0.100 |
Why?
|
| Pancreatic Ducts | 1 | 2012 | 10 | 0.100 |
Why?
|
| Neuroprotective Agents | 1 | 2013 | 52 | 0.100 |
Why?
|
| Carcinoma in Situ | 1 | 2012 | 46 | 0.100 |
Why?
|
| Aging | 1 | 2020 | 976 | 0.100 |
Why?
|
| DNA | 1 | 2014 | 372 | 0.100 |
Why?
|
| Acetyltransferases | 1 | 2011 | 36 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 283 | 0.090 |
Why?
|
| Rats, Transgenic | 2 | 2021 | 12 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2013 | 543 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 297 | 0.080 |
Why?
|
| Linoleoyl-CoA Desaturase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Spermatogenesis | 1 | 2009 | 11 | 0.080 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 74 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2009 | 239 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2009 | 44 | 0.080 |
Why?
|
| Photoreceptor Cells | 1 | 2009 | 36 | 0.080 |
Why?
|
| Actins | 1 | 2009 | 95 | 0.080 |
Why?
|
| Skin | 1 | 2010 | 148 | 0.080 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2008 | 17 | 0.070 |
Why?
|
| Adrenal Glands | 1 | 2008 | 21 | 0.070 |
Why?
|
| Receptor, Insulin | 1 | 2009 | 94 | 0.070 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2008 | 14 | 0.070 |
Why?
|
| Corticosterone | 1 | 2008 | 34 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2008 | 96 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 462 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2021 | 56 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 534 | 0.070 |
Why?
|
| Fatty Acid Desaturases | 3 | 2012 | 15 | 0.060 |
Why?
|
| Vision, Ocular | 1 | 2006 | 27 | 0.060 |
Why?
|
| Octoxynol | 1 | 2005 | 9 | 0.060 |
Why?
|
| Sperm Motility | 2 | 2019 | 15 | 0.060 |
Why?
|
| Sperm Count | 2 | 2019 | 17 | 0.060 |
Why?
|
| Detergents | 1 | 2005 | 24 | 0.060 |
Why?
|
| Gene Expression | 3 | 2014 | 414 | 0.060 |
Why?
|
| Protein Transport | 2 | 2016 | 157 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 82 | 0.050 |
Why?
|
| Adaptation, Ocular | 1 | 2003 | 7 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 8 | 0.050 |
Why?
|
| Genes, Dominant | 2 | 2014 | 35 | 0.050 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2003 | 32 | 0.050 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 4 | 0.050 |
Why?
|
| Centrifugation | 1 | 2023 | 7 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2014 | 208 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 76 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2014 | 187 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2010 | 276 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2018 | 42 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 72 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 117 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 362 | 0.050 |
Why?
|
| Motor Disorders | 1 | 2021 | 9 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2021 | 34 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 15 | 0.050 |
Why?
|
| Cholesterol | 3 | 2008 | 200 | 0.050 |
Why?
|
| Hexokinase | 1 | 2021 | 16 | 0.050 |
Why?
|
| Cerebellum | 1 | 2021 | 42 | 0.050 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 18 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 85 | 0.040 |
Why?
|
| Night Vision | 1 | 2020 | 7 | 0.040 |
Why?
|
| Bruch Membrane | 1 | 2020 | 2 | 0.040 |
Why?
|
| Lipofuscin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 16 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2023 | 1137 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2020 | 99 | 0.040 |
Why?
|
| Semen Analysis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Dietary Fats | 2 | 2009 | 59 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2009 | 55 | 0.040 |
Why?
|
| Transgenes | 2 | 2008 | 63 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 2018 | 14 | 0.040 |
Why?
|
| trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 2 | 2008 | 2 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 43 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 679 | 0.040 |
Why?
|
| NADP | 1 | 2018 | 38 | 0.040 |
Why?
|
| Integrases | 1 | 2018 | 39 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2018 | 69 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2018 | 119 | 0.040 |
Why?
|
| Triglycerides | 1 | 2018 | 120 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 133 | 0.030 |
Why?
|
| Safflower Oil | 2 | 2008 | 3 | 0.030 |
Why?
|
| Cell Line | 2 | 2010 | 694 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 94 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 2017 | 22 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 345 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2016 | 24 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 34 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 656 | 0.030 |
Why?
|
| cis-trans-Isomerases | 1 | 2015 | 27 | 0.030 |
Why?
|
| Papio anubis | 1 | 2015 | 48 | 0.030 |
Why?
|
| Retinitis Pigmentosa | 1 | 2016 | 30 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 201 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 2021 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2005 | 54 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2014 | 13 | 0.030 |
Why?
|
| Tibia | 1 | 2014 | 39 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 407 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 49 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 54 | 0.030 |
Why?
|
| Mosaicism | 1 | 2014 | 14 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 70 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 31 | 0.030 |
Why?
|
| Cartilage, Articular | 1 | 2014 | 44 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 58 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 79 | 0.030 |
Why?
|
| Histidine | 1 | 2014 | 52 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 103 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 132 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 451 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 102 | 0.030 |
Why?
|
| Microsomes | 1 | 2013 | 7 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 250 | 0.030 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2013 | 5 | 0.030 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 1 | 2012 | 1 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2012 | 12 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2013 | 67 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2012 | 19 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 457 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2012 | 68 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 311 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 68 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 689 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 198 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 390 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 445 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 148 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 2731 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 3123 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 755 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 473 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 5416 | 0.020 |
Why?
|
| Cholestadienes | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sperm Head | 1 | 2009 | 2 | 0.020 |
Why?
|
| Flagella | 1 | 2009 | 27 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 804 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 134 | 0.020 |
Why?
|
| Absorption | 1 | 2009 | 14 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 151 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2008 | 13 | 0.020 |
Why?
|
| Light Signal Transduction | 1 | 2008 | 8 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 198 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 47 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent | 1 | 2008 | 1 | 0.020 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2008 | 5 | 0.020 |
Why?
|
| Aldehydes | 1 | 2008 | 55 | 0.020 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2008 | 11 | 0.020 |
Why?
|
| Sterol Esterase | 1 | 2008 | 4 | 0.020 |
Why?
|
| Sterols | 1 | 2008 | 3 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2008 | 60 | 0.020 |
Why?
|
| Neurochemistry | 1 | 2007 | 2 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2008 | 116 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 7164 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 326 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 656 | 0.020 |
Why?
|
| RNA | 1 | 2008 | 111 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 7757 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 985 | 0.020 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2006 | 1 | 0.020 |
Why?
|
| Guanylate Cyclase-Activating Proteins | 1 | 2006 | 3 | 0.020 |
Why?
|
| Transducin | 1 | 2006 | 13 | 0.020 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2006 | 16 | 0.020 |
Why?
|
| Guanylate Cyclase | 1 | 2006 | 15 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2006 | 29 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2006 | 67 | 0.020 |
Why?
|
| Proteins | 1 | 2008 | 251 | 0.020 |
Why?
|
| Linseed Oil | 1 | 2005 | 1 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 38 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 235 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2006 | 162 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 165 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2003 | 17 | 0.010 |
Why?
|
| Animal Husbandry | 1 | 2003 | 9 | 0.010 |
Why?
|
| Pregnancy | 1 | 2005 | 1181 | 0.010 |
Why?
|